Author’s Note: This is an updated version of the post to our blog dated October 30, 2024. Later that day, FDA announced the resolution of Novo Nordisk’s semaglutide shortage, which altered the conclusion of our original post...more
11/4/2024
/ Administrative Procedure Act ,
DQSA ,
Drug Compounding ,
Enforcement ,
False Advertising ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Lanham Act ,
Medical Devices ,
Monopolization ,
Patents ,
Popular ,
Proposed Rules ,
Regulatory Agenda ,
Supply Chain ,
Supply Shortages ,
Unfair Competition ,
Weight-Loss Products
The Corporate Transparency Act became law in the United States on January 1, 2021 and required compliance beginning on January 1, 2024. For more information about the background of the statute, please read our prior articles...more
2/7/2024
/ Anti-Money Laundering ,
Beneficial Owner ,
Compliance ,
Corporate Transparency Act ,
Filing Deadlines ,
FinCEN ,
Ownership Interest ,
Penalties ,
Regulatory Agenda ,
Regulatory Requirements ,
Reporting Requirements ,
Shell Corporations